Aarpik Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-01-2025
- Paid Up Capital ₹ 3.25 M
as on 04-01-2025
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.10 Cr
as on 04-01-2025
- Satisfied Charges ₹ 3.43 Cr
as on 04-01-2025
- Revenue 20.13%
(FY 2022)
- Profit 187.85%
(FY 2022)
- Ebitda -5.58%
(FY 2022)
- Net Worth 38.21%
(FY 2022)
- Total Assets -13.14%
(FY 2022)
About Aarpik Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.25 M.
The company currently has active open charges totaling ₹3.10 Cr. The company has closed loans amounting to ₹3.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manohar Jaiswal and Archna Jaiswal serve as directors at the Company.
- CIN/LLPIN
U24231GJ1995PTC024467
- Company No.
024467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aarpik Pharmaceuticals Private Limited offer?
Aarpik Pharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Antidepressant & Anti Anxiety Medicines, Multivitamin Tablets & Capsules, Antioxidant Capsule, Antibiotic Tablets & Capsules, Cefuroxime Axetil Tablets, Pantoprazole Drugs, Pantoprazole Tablets, Allopathic Cough Syrup.
Who are the key members and board of directors at Aarpik Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Jaiswal  | Managing Director | 03-Aug-1995 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archna Jaiswal | Whole-Time Director | 03-Aug-1995 | Current |
Financial Performance of Aarpik Pharmaceuticals.
Aarpik Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.13% increase. The company also saw a substantial improvement in profitability, with a 187.85% increase in profit. The company's net worth Soared by an impressive increase of 38.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarpik Pharmaceuticals?
Unlock access to Aarpik Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aarpik Remedies Private LimitedActive 27 years 4 monthsManohar Jaiswal and Archna Jaiswal are mutual person
- Totem Biotech Private LimitedActive 21 years 10 months
Manohar Jaiswal and Archna Jaiswal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jan 2024 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2021 | ₹1.00 M | Open |
Others Creation Date: 07 Dec 2016 | ₹8.00 M | Satisfied |
How Many Employees Work at Aarpik Pharmaceuticals?
Aarpik Pharmaceuticals has a workforce of 40 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarpik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarpik Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
